AstraZeneca shares owned by Riverview Capital Advisers
Quarter-by-quarter ownership of AstraZeneca (AZN) shares owned by Riverview Capital Advisers
from 13F filings
Historical chart of Riverview Capital Advisers investment in AstraZeneca
Tip: Access up to 7 years of quarterly data
All positions including AstraZeneca held by Riverview Capital Advisers consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in AstraZeneca by Riverview Capital Advisers
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $873k | 13k | 67.35 |
| 2023-09-30 | $875k | 13k | 67.72 |
| 2023-06-30 | $925k | 13k | 71.57 |
| 2023-03-31 | $897k | 13k | 69.41 |
| 2022-12-31 | $876k | 13k | 67.80 |
| 2022-09-30 | $709k | 13k | 54.84 |
| 2022-06-30 | $854k | 13k | 66.07 |
| 2022-03-31 | $857k | 13k | 66.34 |
| 2021-12-31 | $753k | 13k | 58.25 |
More positions owned by Riverview Capital Advisers
View all positions for Riverview Capital Advisers